세계의 세포 분석 시장 규모, 점유율, 성장 분석(제품 및 서비스별, 수법별, 프로세스별, 최종 사용자별, 지역별) : 산업 예측(2024-2031년)

Global Cell Analysis Market size was valued at USD 19.5 billion in 2022 and is poised to grow from USD 21.61 billion in 2023 to USD 49.08 billion by 2031, growing at a CAGR of 10.80% during the forecast period (2024-2031).

The cell analysis market is poised for significant growth in 2024, driven by the rising incidence of chronic diseases, continuous advancements in cellular analysis technologies, and an uptick in drug discovery activities. As chronic conditions such as cardiovascular diseases, cancers, autoimmune disorders, and rheumatoid arthritis become more prevalent, the demand for effective cellular analysis tools is expected to surge. These tools are critical in identifying potential therapeutic options for patients battling chronic illnesses. The increasing focus on cancer diagnostics highlights this trend, with organizations like Serum Detect gaining recognition for innovative approaches, such as their T-cellular testing nominated by the American Association for Cancer Research (AACR) in March 2024. Such initiatives reflect the healthcare industry's commitment to enhancing cellular diagnostic capabilities, which is essential for market expansion. Additionally, the development of passive bioseparation systems and other advanced technologies in cell analysis has significantly improved both the accuracy and efficiency of results, further bolstering market potential. As the landscape evolves, the integration of cutting-edge technologies and a deeper understanding of chronic diseases will continue to drive growth and innovation within the cell analysis sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cell Analysis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cell Analysis Market Segmental Analysis

Global Cell Analysis Market is segmented into Product & Service, Technique, Process, end user, and region. By Product & Service, the market is classified into Reagents & Consumables, Instruments, Accessories, Software, and Services. Depending on the Technique, it is categorized into Flow Cytometry, PCR, Cell Microarrays, Microscopy, Spectrophotometry, High-Content Screening, and Other Techniques. By Process, the market is classified into Cell Identification, Cell Viability, Cell Signaling Pathway/Signal Transduction, Cell Proliferation, Cell Counting and Quality Control, Cell Interaction, Cell Structure Study, Target Identification and Validation, and Single-Cell Analysis. According to End User, the market is divided into Pharmaceutical and Biotechnology Companies, Hospitals and Clinical Testing Laboratories, Academic and Research Institutes, and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Cell Analysis Market

The Global Cell Analysis market is being significantly propelled by the rising demand for personalized medicine. Advances in molecular biology and genomics are making it possible to tailor treatments to individual patients based on their unique genetic profiles. This shift towards customization in therapeutic approaches is revolutionizing healthcare, as it enhances the understanding of disease mechanisms at the cellular level. Consequently, biotech innovations facilitate improved diagnostics and enable targeted therapies, which contribute to the overall growth of the cell analysis market. This growing trend emphasizes the importance of developing effective and individualized treatment options, further driving market expansion.

Restraints in the Global Cell Analysis Market

One significant constraint facing the global cell analysis market is the elevated costs linked to advanced equipment and technology. Essential tools such as flow cytometers, cell counters, and imaging systems necessitate substantial initial investments, which can be a barrier for smaller laboratories and research institutions. Additionally, the ongoing expenses related to the maintenance and upgrading of these sophisticated devices further impede market expansion. As a result, the financial burden associated with acquiring and sustaining high-quality cell analysis equipment may limit accessibility and capabilities, posing challenges to the overall growth and development of the sector.

Market Trends of the Global Cell Analysis Market

The Global Cell Analysis market is experiencing a significant shift driven by rapid technological advancements in single-cell analysis. As researchers increasingly adopt methods like single-cell RNA sequencing and high-throughput single-cell assays, this trend is unlocking unprecedented insights into cellular processes, differentiation, and disease mechanisms that were previously unattainable with bulk analysis techniques. This innovation is particularly impactful in fields such as cancer research, immunology, and regenerative medicine, fostering enhanced understanding and treatment strategies. As these technologies become more accessible and integrated into standard research and clinical applications, the demand for sophisticated cell analysis tools is projected to continue growing, shaping the market's trajectory through 2024 and beyond.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Technological Advancement
• Regulatory Landscape
• Case Study Analysis
• Customer & Buying Criteria Analysis
• PESTEL Analysis
• Startup Analysis
• Market Attractiveness Index
• Pricing Analysis

Global Cell Analysis Market Size by Product & Service & CAGR (2024-2031)

• Market Overview
• Reagents & Consumables
• Instruments
• Accessories
• Software
• Services

Global Cell Analysis Market Size by Technique & CAGR (2024-2031)

• Market Overview
• Flow Cytometry
• PCR
• Cell Microarrays
• Microscopy
• Spectrophotometry
• High-Content Screening
• Other Techniques

Global Cell Analysis Market Size by Process & CAGR (2024-2031)

• Market Overview
• Cell Identification
• Cell Viability
• Cell Signaling Pathway/Signal Transduction
• Cell Proliferation
• Cell Counting and Quality Control
• Cell Interaction
• Cell Structure Study
• Target Identification and Validation
• Single-Cell Analysis

Global Cell Analysis Market Size by End User & CAGR (2024-2031)

• Market Overview
• Pharmaceutical And Biotechnology Companies
• Hospitals And Clinical Testing Laboratories
• Academic And Research Institutes
• Other End Users

Global Cell Analysis Market Size & CAGR (2024-2031)

• North America, (Product & Service, Technique, Process, End User)
  • US
  • Canada
• Europe, (Product & Service, Technique, Process, End User)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific, (Product & Service, Technique, Process, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America, (Product & Service, Technique, Process, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa, (Product & Service, Technique, Process, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Thermo Fisher Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• General Electric
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGAA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-rad Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Standard Biotools
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Miltenyi Biotec
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Olympus Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biostatus Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nanocellect Biomedical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Creative Bioarray
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meiji Techno
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Promega Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Perkinelmer U.S. LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tecan Trading AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Carl Zeiss AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Qiagen
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation